Pasithea Therapeutics Corp. (KTTAW) Shares Outstanding (2020 - 2026)

Pasithea Therapeutics has disclosed Shares Outstanding (Entity) across 7 years of filings, most recently posting $33.4 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 492.32% year-over-year to $33.4 million; the TTM figure through Jun 2026 stood at $33.4 million (up 492.32% YoY), while the FY2025 annual figure was $7.0 million, up 541.47% from the prior year.
• Shares Outstanding (Entity) came in at $33.4 million for Q2 2026 at Pasithea Therapeutics, up from $24.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $33.4 million in Q2 2026 to a low of $1.0 million in Q4 2023.
• Average Shares Outstanding (Entity) over 5 years is $5.3 million, with a median of $1.3 million recorded in 2023.
• Year-over-year, Shares Outstanding (Entity) declined 21.52% in 2023 and soared 1027.89% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $1.3 million in 2022, then slipped by 20.01% to $1.0 million in 2023, then grew by 5.23% to $1.1 million in 2024, then jumped by 541.47% to $7.0 million in 2025, then soared by 375.24% to $33.4 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $33.4 million in Q2 2026, $24.9 million in Q1 2026, and $7.0 million in Q4 2025.